Zobrazeno 1 - 10
of 452
pro vyhledávání: '"Advanced bladder cancer"'
Autor:
Stephane Schuck, Paul Loussikian, Adel Mebarki, Joelle Malaab, Pierre Foulquié, Manissa Talmatkadi, Mairead Kearney
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Advanced bladder cancer (aBC) is a significant health concern in Europe and has a poor prognosis. Patients with aBC face numerous unmet needs and challenges that significantly impact their quality of life (QoL). This study aims to
Externí odkaz:
https://doaj.org/article/666f7f923b3e4758ae2decd40f5d9b98
Avelumab maintenance therapy for node-positive muscle invasive bladder cancer: a report of two cases
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundMuscle-invasive bladder cancer (MIBC) with nodal involvement is associated with poor prognosis and high mortality. Treatment of node-positive MIBC is complex due to disease heterogeneity and a lack of evidence-based treatment options, espec
Externí odkaz:
https://doaj.org/article/d7516fd94c1143f3b7ee574255f28e2b
Autor:
Harshit Garg, Mukund Bhandari, Furkan Dursun, Michael A. Liss, Dharam Kaushik, Robert S. Svatek, Ahmed M. Mansour
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
IntroductionThe management of non-metastatic clinically advanced lymph nodal (cN2/N3) bladder cancer (Stage IIIB) could involve radical cystectomy, chemoradiation, or systemic therapy alone. However, a definitive comparison between these approaches i
Externí odkaz:
https://doaj.org/article/b432edb1fe064110888a701d52ed3bd3
Autor:
Ryohta Nakamura, Go Hasegawa, Kazumasa Ohashi, Takehisa Hashimoto, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama
Publikováno v:
IJU Case Reports, Vol 6, Iss 1, Pp 85-88 (2023)
Introduction We report a patient with the complete remission of multiple metastases and primary bladder lesions of bladder cancer who developed primary lung cancer requiring radical resection. Case presentation A 68‐year‐old man diagnosed with in
Externí odkaz:
https://doaj.org/article/ab56b1ae05604d328039f277cce51d83
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Considering its speedy development and extremely low 5-year overall survival rate worldwide, bladder cancer (BCa) is one of the most common and highly malignant tumors. Increasing evidence suggests that protein-coding mRNAs and non-coding RNAs, inclu
Externí odkaz:
https://doaj.org/article/a027a627b8b04f699b40be9c4aeb399a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 2, Iss 4, Pp 28-34 (2016)
Bladder cancer (BC) is an important clinical and scientific challenge. In 2013, in Russia, the absolute number of patients with first-ever diagnosis of bladder cancer was 12 992 people. There is an increasing proportion of detection of bladder cancer
Externí odkaz:
https://doaj.org/article/fa431a851c074005a7160aa350f39139
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gabriella Del Bene, Fabio Calabrò, Diana Giannarelli, Elizabeth R. Plimack, Lauren C. Harshman, Evan Y. Yu, Simon J. Crabb, Sumanta Kumar Pal, Ajjai S. Alva, Thomas Powles, Ugo De Giorgi, Neeraj Agarwal, Aristotelis Bamias, Sylvain Ladoire, Andrea Necchi, Ulka N. Vaishampayan, Günter Niegisch, Joaquim Bellmunt, Jack Baniel, Matthew D. Galsky, Cora N. Sternberg
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: MIBC is an aggressive disease, with 5-year survival rates ranging from 36 to 48% for p T3/p T4/p N+tumors. Perioperative treatment can improve overall survival, with more robust evidence in favor of neoadjuvant chemotherapy. Few randomize
Externí odkaz:
https://doaj.org/article/07c29ee921bc45cdbbe4ef5cab278458